BTC/USD

The Federal Reserve has for decades moved steadily from a remote, opaque government agency that shared little about what it did or why to a more transparent institution willing to explain how it makes decisions and what it thinks about the economy. But in his first press conference Wednesday, new chair Kevin Warsh began to reverse some of those steps. ...

Last week was momentous. There was a fragile 60-day de-escalation during negotiations between Washington and Tehran. However, the allies of both (Hezbollah and Israel) continue to clash, stalling talks. Still, oil prices tumbled 7-9%. At the same time, a new era at the Federal Reserve has begun. The new chair eschews forward guidance, and this was reflected ...

Two men were arrested on Friday (Jun 19) for allegedly stealing a diamond worth over S$235,000 (US$182,000) from a jewellery store after replacing it with a fake. In a news release on Saturday, the Singapore Police Force (SPF) said it received a call for assistance at about 3.40pm on Friday and was informed that a diamond had been stolen from a jewellery ...

The Federal Reserve is a sprawling bureaucracy, averse to change. With that in mind, the latest FOMC meeting and press conference — the first under new Fed Chair Kevin Warsh — came as a pleasant surprise. The Fed held its target for the federal funds rate at 3.5% to 3.75%. While that decision itself was routine (markets had treated it as a near-certainty), ...

The term “rate cut” is effectively banished in central bank circles right now. Rumour has it that any mention of The Policy Change That Must Not Be Named at the European Central Bank gets you turned into a frog. Or worse, sent for mandatory training at the German Bundesbank, where someone lectures you about the “1970s” for several hours… Best not mention it ...

Elon Musk’s ex Ashley St. Clair claims she turned down a multi-million-dollar NDA from the newly minted trillionaire after giving birth to his 13th child. “It was a shock, especially the way in which [the NDA] was presented over disappearing Signal messages,” she alleged on the June 16th episode of the “Don Lemon Show” podcast. St. Clair, 27, says she was ...

NEW: President Trump told NBC News in a phone call he spoke with Israel earlier today and asked them to agree to a ceasefire w/Hezbollah. "It's a positive," he said. "It's a little icing on the cake." He declined to specify whether he had talked to PM Netanyahu directly.

Torsten Slok, Apollo Global chief economist, joins 'Power Lunch' to discuss the latest Federal Reserve meeting, the stronger signal for the central bank and much more.

The Office of the United States Trade Representative and Mexico’s Secretariat of Economy held the second round of bilateral negotiations related to the Joint Review of the United States-Mexico-Canada Agreement (USMCA) on June 15-17, 2026, in Washington, D.C. In addition, today U.S. Trade Representative Jamieson Greer and Mexican Secretary of Economy Marcelo ...

*US STARTS SECTION 301 PROBE OF GERMANY OVER PHARMACEUTICALS USTR Announces Initiation of Section 301 Investigation of Germany’s Persistent Underpayment for Innovative Pharmaceutical Products Today, U.S. Trade Representative Jamieson Greer initiated an investigation under Section 301 of the Trade Act of 1974 against Germany. This investigation will seek to determine whether persistent underpayment for innovative pharmaceutical products by Germany is unreasonable or discriminatory and burdens or restricts U.S. commerce. This investigation follows months of meaningful discussions with our German partners in an effort to resolve this issue. “President Trump has made clear that American patients should not be shouldering a disproportionate share of global pharmaceutical research and development,” said Ambassador Greer. “I am particularly concerned with news that Germany is fast-tracking legislation that would further reduce its spending on innovative pharmaceuticals. This is a serious step backwards at a time when our trading partners need to step up and start paying their fair share to fund innovative pharmaceutical research and development. We believe that the United States and Germany can find a path forward that expands access to the most innovative drugs for the German people while ensuring fair reimbursement for the pharmaceuticals made by American workers." “On April 2, 2026, the United States and the United Kingdom announced a ground-breaking arrangement on pharmaceutical pricing that will help drive investment and innovation in both countries. Germany should follow suit with constructive negotiations to address this imbalance.” “Fighting the war against disease is a shared burden across wealthy nations,” said U.S. Department of Health and Human Services Secretary Robert F. Kennedy, Jr. “The United States is calling on Germany to pay its fair share for the innovative treatments its people use. I commend Ambassador Greer for his leadership in confronting this imbalance. Fair reimbursement strengthens medical innovation and helps ensure the development of the next generation of lifesaving cures.”